RhumbLine Advisers
CLPT icon

RhumbLine Advisers’s ClearPoint Neuro CLPT Stock Holding History

RhumbLine Advisers’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$423K Buy
34,664
+807
+2% +$12.1K ﹤0.01% 2839
2026
Q2 		$604K Buy
33,857
+2,353
+7% +$29.4K ﹤0.01% 2645
2026
Q1 		$287K Buy
31,504
+60
+0.2% +$758 ﹤0.01% 2928
2025
Q4 		$430K Sell
31,444
-4,302
-12% -$79.7K ﹤0.01% 2764
2025
Q3 		$779K Sell
35,746
-1,903
-5% -$22.4K ﹤0.01% 2398
2025
Q2 		$450K Buy
+37,649
New +$474K ﹤0.01% 2747
2024
Q3 		– Sell
-5,759
Closed -$31K – 4223
2024
Q2 		$31K Sell
5,759
-16,443
-74% -$95.2K ﹤0.01% 3799
2024
Q1 		$151K Buy
22,202
+1,110
+5% +$7.76K ﹤0.01% 3300
2023
Q4 		$143K Sell
21,092
-9,265
-31% -$52.4K ﹤0.01% 3333
2023
Q3 		$152K Buy
30,357
+2,126
+8% +$12.7K ﹤0.01% 3303
2023
Q2 		$204K Buy
+28,231
New +$240K ﹤0.01% 3234
2022
Q2 		– Sell
-17,681
Closed -$184K – 3119
2022
Q1 		$184K Buy
17,681
+4,862
+38% +$44.3K ﹤0.01% 2776
2021
Q4 		$144K Sell
12,819
-334
-3% -$5K ﹤0.01% 2893
2021
Q3 		$233K Buy
13,153
+1,249
+10% +$23.4K ﹤0.01% 2852
2021
Q2 		$227K Buy
+11,904
New +$230K ﹤0.01% 2892

Other funds holding CLPT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Lane Generational
Lane Generational Dover, Massachusetts $111M AUM 16.63% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Compass Financial Management
Compass Financial Management Tampa, Florida $926M AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

RhumbLine Advisers's CLPT Position: Q3 2026 in Review

RhumbLine Advisers increased its ClearPoint Neuro (CLPT) stake by 2.4% in Q3 2026, buying an estimated $12.1K and bringing the position to 34,664 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

RhumbLine Advisers first reported a position in CLPT in Q2 2021 and has held it in 15 quarters since. The position peaked at $779K in Q3 2025. 89 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • RhumbLine Advisers held 34,664 shares of ClearPoint Neuro worth $423K as of Q3 2026.
  • RhumbLine Advisers bought 807 ClearPoint Neuro shares in Q3 2026, an estimated $12.1K.
  • ClearPoint Neuro made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2839 holding.
  • RhumbLine Advisers first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 15 quarters since.
  • RhumbLine Advisers's ClearPoint Neuro position peaked at $779K in Q3 2025.
  • 89 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.